Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study

Abstract Background Observational studies have suggested that telomere length is associated with amyotrophic lateral sclerosis (ALS). However, whether this association is causal remains unclear. In this study, we aimed to explore the causal relationship between leukocyte telomere length (LTL) and AL...

Full description

Bibliographic Details
Main Authors: Kailin Xia, Linjing Zhang, Gan Zhang, Yajun Wang, Tao Huang, Dongsheng Fan
Format: Article
Language:English
Published: BMC 2021-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-021-02135-2
_version_ 1819096143835955200
author Kailin Xia
Linjing Zhang
Gan Zhang
Yajun Wang
Tao Huang
Dongsheng Fan
author_facet Kailin Xia
Linjing Zhang
Gan Zhang
Yajun Wang
Tao Huang
Dongsheng Fan
author_sort Kailin Xia
collection DOAJ
description Abstract Background Observational studies have suggested that telomere length is associated with amyotrophic lateral sclerosis (ALS). However, whether this association is causal remains unclear. In this study, we aimed to explore the causal relationship between leukocyte telomere length (LTL) and ALS by a two-sample Mendelian randomization (MR) approach. Single-nucleotide polymorphisms (SNPs) for LTL were identified through high-quality genome-wide association studies (GWASs). The ALS GWAS summary data (20,806 cases; 59,804 controls) with largest sample size to date was obtained. We adopted the inverse variance weighted (IVW) method to examine the effect of LTL on ALS and used the weighted median method, simple median method, MR Egger method and MR-PRESSO method to perform sensitivity analyses. Results We found that genetically determined increased LTL was inversely associated with the risk of ALS (odds ratio (OR) = 0.846, 95% confidence interval (CI): 0.744–0.962, P = 0.011), which was mainly driven by rs940209 in the OBFC1 gene, suggesting a potential effect of OBFC1 on ALS. The results were further confirmed by sensitivity analysis with the MR Egger method (OR = 0.647, 95% CI = 0.447–0.936, P = 0.050). Analyses by the weighted median method (OR = 0.893, P = 0.201) and simple median method (OR = 0.935, P = 0.535) also showed a similar trend. The MR Egger analysis did not suggest directional pleiotropy, with an intercept of 0.025 (P = 0.168). Neither the influence of instrumental outliers nor heterogeneity was found. Conclusions Our results suggest that genetically predicted increased LTL has a causal relationship with a lower risk of ALS. Protecting against telomere loss may be of great importance in the prevention and treatment of ALS.
first_indexed 2024-12-21T23:54:31Z
format Article
id doaj.art-91e3668420c645199a1f030d2ea92afc
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-21T23:54:31Z
publishDate 2021-12-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-91e3668420c645199a1f030d2ea92afc2022-12-21T18:45:50ZengBMCOrphanet Journal of Rare Diseases1750-11722021-12-011611810.1186/s13023-021-02135-2Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization studyKailin Xia0Linjing Zhang1Gan Zhang2Yajun Wang3Tao Huang4Dongsheng Fan5Department of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Epidemiology and Biostatistics, School of Public Health, Peking UniversityDepartment of Neurology, Peking University Third HospitalAbstract Background Observational studies have suggested that telomere length is associated with amyotrophic lateral sclerosis (ALS). However, whether this association is causal remains unclear. In this study, we aimed to explore the causal relationship between leukocyte telomere length (LTL) and ALS by a two-sample Mendelian randomization (MR) approach. Single-nucleotide polymorphisms (SNPs) for LTL were identified through high-quality genome-wide association studies (GWASs). The ALS GWAS summary data (20,806 cases; 59,804 controls) with largest sample size to date was obtained. We adopted the inverse variance weighted (IVW) method to examine the effect of LTL on ALS and used the weighted median method, simple median method, MR Egger method and MR-PRESSO method to perform sensitivity analyses. Results We found that genetically determined increased LTL was inversely associated with the risk of ALS (odds ratio (OR) = 0.846, 95% confidence interval (CI): 0.744–0.962, P = 0.011), which was mainly driven by rs940209 in the OBFC1 gene, suggesting a potential effect of OBFC1 on ALS. The results were further confirmed by sensitivity analysis with the MR Egger method (OR = 0.647, 95% CI = 0.447–0.936, P = 0.050). Analyses by the weighted median method (OR = 0.893, P = 0.201) and simple median method (OR = 0.935, P = 0.535) also showed a similar trend. The MR Egger analysis did not suggest directional pleiotropy, with an intercept of 0.025 (P = 0.168). Neither the influence of instrumental outliers nor heterogeneity was found. Conclusions Our results suggest that genetically predicted increased LTL has a causal relationship with a lower risk of ALS. Protecting against telomere loss may be of great importance in the prevention and treatment of ALS.https://doi.org/10.1186/s13023-021-02135-2Amyotrophic lateral sclerosisLeukocyte telomere lengthMendelian randomizationRisk factors
spellingShingle Kailin Xia
Linjing Zhang
Gan Zhang
Yajun Wang
Tao Huang
Dongsheng Fan
Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
Orphanet Journal of Rare Diseases
Amyotrophic lateral sclerosis
Leukocyte telomere length
Mendelian randomization
Risk factors
title Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
title_full Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
title_fullStr Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
title_full_unstemmed Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
title_short Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study
title_sort leukocyte telomere length and amyotrophic lateral sclerosis a mendelian randomization study
topic Amyotrophic lateral sclerosis
Leukocyte telomere length
Mendelian randomization
Risk factors
url https://doi.org/10.1186/s13023-021-02135-2
work_keys_str_mv AT kailinxia leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy
AT linjingzhang leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy
AT ganzhang leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy
AT yajunwang leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy
AT taohuang leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy
AT dongshengfan leukocytetelomerelengthandamyotrophiclateralsclerosisamendelianrandomizationstudy